Bonit Capital

Bonit Capital is a Swedish family-owned investment company with a clear mission of making sustainable and impactful investments, aiming to enable global innovation. The company invests across sectors and asset classes, including social investments and outcome models. Their roots are in the life science sector, which remains a focus area, but they also invest in other sectors and asset classes, seeking meaningful and entrepreneurial approaches to investing. They are guided by a belief that innovation and responsible private sector initiatives hold the potential to successfully meet and support the challenges of today's societies. They invest in companies and organizations with financially viable solutions to global sustainability themes.

In the venture capital segment, Bonit Capital invests in ambitious founders within the life science sector, focusing on digital health, medical technology, and diagnostics. They take an active ownership approach by providing capital, industry expertise, and access to an international network. In the private equity segment, they invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, aiming to produce superior returns and meaningful portfolio diversification. Among their main holdings is Elekta AB, a world-leading medtech company founded by Laurent Leksell.

Bonit Capital also owns Leksell Social Ventures (LSV), an impact investment fund with a focus on outcome models and direct investments in the areas of mental health, education, and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development, and networking with private, public, and nonprofit actors.